Selected research
Market Outlook & Growth Opportunities
Global Onsite Medical Market Outlook and Growth Opportunities 2026
Market perspective
The global Onsite Medical market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Onsite Medical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Onsite Medical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Onsite Medical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Onsite Medical market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Onsite Medical market include Mobile Medical Corporation, QuadMed, HSP Group, Medcor, Eden Health, ProgressiveHealth, Work Health Solutions, MedExpress and OnSite Health, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Onsite Medical market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Onsite Medical and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Onsite Medical revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Onsite Medical market.
Onsite Medical Segment by Company
Mobile Medical Corporation
QuadMed
HSP Group
Medcor
Eden Health
ProgressiveHealth
Work Health Solutions
MedExpress
OnSite Health
NeoPath
Concentra
CareATC
Premise Health
PMR Healthcare
WorkCare
Onsite Medical Segment by Type
Health Examination
Acute Care
Primary Health Care
Others
Onsite Medical Segment by Application
School
Enterprise
Building Site
Others
Onsite Medical Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Onsite Medical status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Onsite Medical key companies, revenue, market share, and recent developments.
3. To split the Onsite Medical breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Onsite Medical market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Onsite Medical significant trends, drivers, influence factors in global and regions.
6. To analyze Onsite Medical competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Onsite Medical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Onsite Medical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Onsite Medical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Onsite Medical industry.
Chapter 3: Detailed analysis of Onsite Medical company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Onsite Medical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Onsite Medical in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Health Examination
- Acute Care
- Primary Health Care
- Others
Applications
- School
- Enterprise
- Building Site
- Others
Companies covered
- Mobile Medical Corporation
- QuadMed
- HSP Group
- Medcor
- Eden Health
- ProgressiveHealth
- Work Health Solutions
- MedExpress
- OnSite Health
- NeoPath
- Concentra
- CareATC
- Premise Health
- PMR Healthcare
- WorkCare
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Onsite Medical Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Onsite Medical Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Onsite Medical Market Dynamics
- 2.1 Onsite Medical Industry Trends
- 2.2 Onsite Medical Industry Drivers
- 2.3 Onsite Medical Industry Opportunities and Challenges
- 2.4 Onsite Medical Industry Restraints
3 Onsite Medical Market by Company
- 3.1 Global Onsite Medical Company Revenue Ranking in 2025
- 3.2 Global Onsite Medical Revenue by Company (2021-2026)
- 3.3 Global Onsite Medical Company Ranking (2024-2026)
- 3.4 Global Onsite Medical Company Manufacturing Base and Headquarters
- 3.5 Global Onsite Medical Company Product Type and Application
- 3.6 Global Onsite Medical Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Onsite Medical Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Onsite Medical Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Onsite Medical Market by Type
- 4.1 Onsite Medical Type Introduction
- 4.1.1 Health Examination
- 4.1.2 Acute Care
- 4.1.3 Primary Health Care
- 4.1.4 Others
- 4.2 Global Onsite Medical Sales Value by Type
- 4.2.1 Global Onsite Medical Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Onsite Medical Sales Value by Type (2021-2032)
- 4.2.3 Global Onsite Medical Sales Value Share by Type (2021-2032)
5 Onsite Medical Market by Application
- 5.1 Onsite Medical Application Introduction
- 5.1.1 School
- 5.1.2 Enterprise
- 5.1.3 Building Site
- 5.1.4 Others
- 5.2 Global Onsite Medical Sales Value by Application
- 5.2.1 Global Onsite Medical Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Onsite Medical Sales Value by Application (2021-2032)
- 5.2.3 Global Onsite Medical Sales Value Share by Application (2021-2032)
6 Onsite Medical Regional Value Analysis
- 6.1 Global Onsite Medical Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Onsite Medical Sales Value by Region (2021-2032)
- 6.2.1 Global Onsite Medical Sales Value by Region: 2021-2026
- 6.2.2 Global Onsite Medical Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Onsite Medical Sales Value (2021-2032)
- 6.3.2 North America Onsite Medical Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Onsite Medical Sales Value (2021-2032)
- 6.4.2 Europe Onsite Medical Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Onsite Medical Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Onsite Medical Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Onsite Medical Sales Value (2021-2032)
- 6.6.2 South America Onsite Medical Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Onsite Medical Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Onsite Medical Sales Value Share by Country, 2025 VS 2032
7 Onsite Medical Country-level Value Analysis
- 7.1 Global Onsite Medical Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Onsite Medical Sales Value by Country (2021-2032)
- 7.2.1 Global Onsite Medical Sales Value by Country (2021-2026)
- 7.2.2 Global Onsite Medical Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.7.2 France Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.14.2 China Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.17.2 India Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Onsite Medical Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Onsite Medical Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Onsite Medical Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Onsite Medical Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Mobile Medical Corporation
- 8.1.1 Mobile Medical Corporation Company Information
- 8.1.2 Mobile Medical Corporation Business Overview
- 8.1.3 Mobile Medical Corporation Onsite Medical Revenue and Gross Margin (2021-2026)
- 8.1.4 Mobile Medical Corporation Onsite Medical Product Portfolio
- 8.1.5 Mobile Medical Corporation Recent Developments
- 8.2 QuadMed
- 8.2.1 QuadMed Company Information
- 8.2.2 QuadMed Business Overview
- 8.2.3 QuadMed Onsite Medical Revenue and Gross Margin (2021-2026)
- 8.2.4 QuadMed Onsite Medical Product Portfolio
- 8.2.5 QuadMed Recent Developments
- 8.3 HSP Group
- 8.3.1 HSP Group Company Information
- 8.3.2 HSP Group Business Overview
- 8.3.3 HSP Group Onsite Medical Revenue and Gross Margin (2021-2026)
- 8.3.4 HSP Group Onsite Medical Product Portfolio
- 8.3.5 HSP Group Recent Developments
- 8.4 Medcor
- 8.4.1 Medcor Company Information
- 8.4.2 Medcor Business Overview
- 8.4.3 Medcor Onsite Medical Revenue and Gross Margin (2021-2026)
- 8.4.4 Medcor Onsite Medical Product Portfolio
- 8.4.5 Medcor Recent Developments
- 8.5 Eden Health
- 8.5.1 Eden Health Company Information
- 8.5.2 Eden Health Business Overview
- 8.5.3 Eden Health Onsite Medical Revenue and Gross Margin (2021-2026)
- 8.5.4 Eden Health Onsite Medical Product Portfolio
- 8.5.5 Eden Health Recent Developments
- 8.6 ProgressiveHealth
- 8.6.1 ProgressiveHealth Company Information
- 8.6.2 ProgressiveHealth Business Overview
- 8.6.3 ProgressiveHealth Onsite Medical Revenue and Gross Margin (2021-2026)
- 8.6.4 ProgressiveHealth Onsite Medical Product Portfolio
- 8.6.5 ProgressiveHealth Recent Developments
- 8.7 Work Health Solutions
- 8.7.1 Work Health Solutions Company Information
- 8.7.2 Work Health Solutions Business Overview
- 8.7.3 Work Health Solutions Onsite Medical Revenue and Gross Margin (2021-2026)
- 8.7.4 Work Health Solutions Onsite Medical Product Portfolio
- 8.7.5 Work Health Solutions Recent Developments
- 8.8 MedExpress
- 8.8.1 MedExpress Company Information
- 8.8.2 MedExpress Business Overview
- 8.8.3 MedExpress Onsite Medical Revenue and Gross Margin (2021-2026)
- 8.8.4 MedExpress Onsite Medical Product Portfolio
- 8.8.5 MedExpress Recent Developments
- 8.9 OnSite Health
- 8.9.1 OnSite Health Company Information
- 8.9.2 OnSite Health Business Overview
- 8.9.3 OnSite Health Onsite Medical Revenue and Gross Margin (2021-2026)
- 8.9.4 OnSite Health Onsite Medical Product Portfolio
- 8.9.5 OnSite Health Recent Developments
- 8.10 NeoPath
- 8.10.1 NeoPath Company Information
- 8.10.2 NeoPath Business Overview
- 8.10.3 NeoPath Onsite Medical Revenue and Gross Margin (2021-2026)
- 8.10.4 NeoPath Onsite Medical Product Portfolio
- 8.10.5 NeoPath Recent Developments
- 8.11 Concentra
- 8.11.1 Concentra Company Information
- 8.11.2 Concentra Business Overview
- 8.11.3 Concentra Onsite Medical Revenue and Gross Margin (2021-2026)
- 8.11.4 Concentra Onsite Medical Product Portfolio
- 8.11.5 Concentra Recent Developments
- 8.12 CareATC
- 8.12.1 CareATC Company Information
- 8.12.2 CareATC Business Overview
- 8.12.3 CareATC Onsite Medical Revenue and Gross Margin (2021-2026)
- 8.12.4 CareATC Onsite Medical Product Portfolio
- 8.12.5 CareATC Recent Developments
- 8.13 Premise Health
- 8.13.1 Premise Health Company Information
- 8.13.2 Premise Health Business Overview
- 8.13.3 Premise Health Onsite Medical Revenue and Gross Margin (2021-2026)
- 8.13.4 Premise Health Onsite Medical Product Portfolio
- 8.13.5 Premise Health Recent Developments
- 8.14 PMR Healthcare
- 8.14.1 PMR Healthcare Company Information
- 8.14.2 PMR Healthcare Business Overview
- 8.14.3 PMR Healthcare Onsite Medical Revenue and Gross Margin (2021-2026)
- 8.14.4 PMR Healthcare Onsite Medical Product Portfolio
- 8.14.5 PMR Healthcare Recent Developments
- 8.15 WorkCare
- 8.15.1 WorkCare Company Information
- 8.15.2 WorkCare Business Overview
- 8.15.3 WorkCare Onsite Medical Revenue and Gross Margin (2021-2026)
- 8.15.4 WorkCare Onsite Medical Product Portfolio
- 8.15.5 WorkCare Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst